SG10201604559TA - Chromatography matrices including novel staphylococcus aureus protein a based ligands - Google Patents

Chromatography matrices including novel staphylococcus aureus protein a based ligands

Info

Publication number
SG10201604559TA
SG10201604559TA SG10201604559TA SG10201604559TA SG10201604559TA SG 10201604559T A SG10201604559T A SG 10201604559TA SG 10201604559T A SG10201604559T A SG 10201604559TA SG 10201604559T A SG10201604559T A SG 10201604559TA SG 10201604559T A SG10201604559T A SG 10201604559TA
Authority
SG
Singapore
Prior art keywords
staphylococcus aureus
based ligands
including novel
aureus protein
matrices including
Prior art date
Application number
SG10201604559TA
Inventor
Spector Shari
Smith Robert
Orlando Joe
Bian Nanying
Original Assignee
Emd Millipore Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Emd Millipore Corp filed Critical Emd Millipore Corp
Publication of SG10201604559TA publication Critical patent/SG10201604559TA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 - B01D15/36
    • B01D15/3804—Affinity chromatography
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 - B01D15/36
    • B01D15/3804—Affinity chromatography
    • B01D15/3809—Affinity chromatography of the antigen-antibody type, e.g. protein A, G, L chromatography
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/281—Sorbents specially adapted for preparative, analytical or investigative chromatography
    • B01J20/286—Phases chemically bonded to a substrate, e.g. to silica or to polymers
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/30—Processes for preparing, regenerating, or reactivating
    • B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
    • B01J20/3231—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the coating or impregnating layer
    • B01J20/3242—Layers with a functional group, e.g. an affinity material, a ligand, a reactant or a complexing group
    • B01J20/3268—Macromolecular compounds
    • B01J20/3272—Polymers obtained by reactions otherwise than involving only carbon to carbon unsaturated bonds
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/30—Processes for preparing, regenerating, or reactivating
    • B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
    • B01J20/3231—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the coating or impregnating layer
    • B01J20/3242—Layers with a functional group, e.g. an affinity material, a ligand, a reactant or a complexing group
    • B01J20/3268—Macromolecular compounds
    • B01J20/3272—Polymers obtained by reactions otherwise than involving only carbon to carbon unsaturated bonds
    • B01J20/3274—Proteins, nucleic acids, polysaccharides, antibodies or antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1271—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Micrococcaceae (F), e.g. Staphylococcus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SG10201604559TA 2011-06-08 2012-05-29 Chromatography matrices including novel staphylococcus aureus protein a based ligands SG10201604559TA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201161494701P 2011-06-08 2011-06-08

Publications (1)

Publication Number Publication Date
SG10201604559TA true SG10201604559TA (en) 2016-07-28

Family

ID=46229293

Family Applications (3)

Application Number Title Priority Date Filing Date
SG2012039533A SG186552A1 (en) 2011-06-08 2012-05-29 Chromatography matrices including novel staphylococcus aureus protein a based ligands
SG10201604554WA SG10201604554WA (en) 2011-06-08 2012-05-29 Chromatography matrices including novel staphylococcus aureus protein a based ligands
SG10201604559TA SG10201604559TA (en) 2011-06-08 2012-05-29 Chromatography matrices including novel staphylococcus aureus protein a based ligands

Family Applications Before (2)

Application Number Title Priority Date Filing Date
SG2012039533A SG186552A1 (en) 2011-06-08 2012-05-29 Chromatography matrices including novel staphylococcus aureus protein a based ligands
SG10201604554WA SG10201604554WA (en) 2011-06-08 2012-05-29 Chromatography matrices including novel staphylococcus aureus protein a based ligands

Country Status (13)

Country Link
US (5) US8754196B2 (en)
EP (2) EP3053931B1 (en)
JP (4) JP5756428B2 (en)
KR (3) KR101464040B1 (en)
CN (2) CN102895960B (en)
AU (3) AU2012366229C1 (en)
DK (2) DK3053931T3 (en)
ES (2) ES2671722T3 (en)
IL (2) IL229774A (en)
RU (2) RU2595430C2 (en)
SG (3) SG186552A1 (en)
TW (3) TWI638828B (en)
WO (1) WO2013109302A2 (en)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040067532A1 (en) 2002-08-12 2004-04-08 Genetastix Corporation High throughput generation and affinity maturation of humanized antibody
US8877688B2 (en) 2007-09-14 2014-11-04 Adimab, Llc Rationally designed, synthetic antibody libraries and uses therefor
BRPI0816785A2 (en) 2007-09-14 2017-05-02 Adimab Inc rationally designed synthetic antibody libraries, and uses thereof
US8592555B2 (en) 2008-08-11 2013-11-26 Emd Millipore Corporation Immunoglobulin-binding proteins with improved specificity
SG195555A1 (en) 2008-12-24 2013-12-30 Emd Millipore Corp Caustic stable chromatography ligands
SG186552A1 (en) * 2011-06-08 2013-01-30 Emd Millipore Corp Chromatography matrices including novel staphylococcus aureus protein a based ligands
WO2013081540A1 (en) * 2011-11-30 2013-06-06 Ge Healthcare Bio-Sciences Ab Affinity chromatography matrix
CN104411820B (en) 2012-06-29 2017-05-03 Emd密理博公司 Methods for inactivating viruses during a protein purification process
EP2682168A1 (en) 2012-07-02 2014-01-08 Millipore Corporation Purification of biological molecules
CN104768536B (en) 2012-09-17 2019-03-29 格雷斯公司 It is functionalized microparticle support material and its preparation and application
ES2868093T3 (en) 2012-09-17 2021-10-21 Grace W R & Co Chromatography media and devices
US10472389B2 (en) 2013-03-14 2019-11-12 Emd Millipore Corporation Methods of increasing protein purity using protein A based chromatography
CN105377880B (en) 2013-07-10 2020-08-07 通用电气医疗集团生物工艺研发股份公司 Mutated immunoglobulin-binding polypeptides
CA2923133C (en) * 2013-09-04 2019-05-28 Emd Millipore Corporation Methods of cleaning a protein a based affinity chromatography column
EP3094390B1 (en) * 2014-01-16 2021-07-07 W.R. Grace & CO. - CONN. Affinity chromatography media and chromatography devices
US11389783B2 (en) 2014-05-02 2022-07-19 W.R. Grace & Co.-Conn. Functionalized support material and methods of making and using functionalized support material
EP2985076B1 (en) * 2014-08-15 2022-03-30 Merck Patent GmbH Purification of immunoglobulins from plasma
US11566082B2 (en) * 2014-11-17 2023-01-31 Cytiva Bioprocess R&D Ab Mutated immunoglobulin-binding polypeptides
CN104399283B (en) * 2014-12-04 2016-02-17 江西省农业科学院农产品质量安全与标准研究所 The preparation method of AFB1 aptamers affinity column
CN104645949B (en) * 2015-02-04 2017-01-25 浙江大学 Affinity chromatography medium employing tetrapeptide as functional ligand and preparation method of affinity chromatography medium
KR20170115535A (en) 2015-02-05 2017-10-17 미쯔비시 케미컬 주식회사 A protein having affinity for immunoglobulin, an affinity separator using the same, a column for liquid chromatography
JP6738340B2 (en) 2015-02-06 2020-08-12 ナフィゴ プロテインズ ゲゼルシャフト ミット ベシュレンクテル ハフツングＮａｖｉｇｏ Ｐｒｏｔｅｉｎｓ ＧｍｂＨ Novel EGFR binding protein
GB201503578D0 (en) * 2015-03-03 2015-04-15 Ge Healthcare Bio Sciences Ab Sanitization method for affinity chromatography matrices
JP6705806B2 (en) * 2015-03-26 2020-06-03 Jsr株式会社 Immunoglobulin binding protein and affinity carrier using the same
EP3578571A1 (en) * 2015-04-13 2019-12-11 Fujifilm Corporation Method for producing short-chain peptide-immobilized carrier, and short-chain peptide-immobilized carrier
US10695744B2 (en) 2015-06-05 2020-06-30 W. R. Grace & Co.-Conn. Adsorbent biprocessing clarification agents and methods of making and using the same
AU2016293063B2 (en) * 2015-07-16 2018-11-08 Navigo Proteins Gmbh Novel immunoglobulin-binding proteins and their use in affinity purification
CA2991815A1 (en) 2015-07-20 2017-01-26 Navigo Proteins Gmbh Novel binding proteins based on di-ubiquitin muteins and methods for generation
GB201515339D0 (en) * 2015-08-28 2015-10-14 Ge Healthcare Bio Sciences Ab A seperation matrix and a method of seperating antibodies
US10697983B2 (en) 2015-09-08 2020-06-30 Merck Patent Gmbh Methods of evaluating quality of media suitable for removing anti-A or anti-B antibodies
US10697982B2 (en) * 2015-09-08 2020-06-30 Merck Patent Gmbh Methods of evaluating quality of a chromatography media which binds anti-A or anti-B antibodies
CN105413644A (en) * 2015-12-02 2016-03-23 南昌大学 Affinity adsorption material based on single domain heavy chain antibody specifically binding to aflatoxin
KR101993845B1 (en) * 2016-02-18 2019-06-28 (주)에이피테크놀로지 Antibody binding affinity ligand with advanced alkali resistance
JP2019526526A (en) 2016-05-04 2019-09-19 ナフィゴ プロテインズ ゲゼルシャフト ミット ベシュレンクテル ハフツングＮａｖｉｇｏ Ｐｒｏｔｅｉｎｓ ＧｍｂＨ Target compounds for site-specific coupling of chemical moieties containing peptide linkers
EP3455241B1 (en) 2016-05-11 2022-02-23 Cytiva BioProcess R&D AB Method of cleaning and/or sanitizing a separation matrix
US10703774B2 (en) 2016-09-30 2020-07-07 Ge Healthcare Bioprocess R&D Ab Separation method
WO2017194592A1 (en) 2016-05-11 2017-11-16 Ge Healthcare Bioprocess R&D Ab Method of storing a separation matrix
US10654887B2 (en) 2016-05-11 2020-05-19 Ge Healthcare Bio-Process R&D Ab Separation matrix
US10730908B2 (en) 2016-05-11 2020-08-04 Ge Healthcare Bioprocess R&D Ab Separation method
US10889615B2 (en) 2016-05-11 2021-01-12 Cytiva Bioprocess R&D Ab Mutated immunoglobulin-binding polypeptides
CN109071613A (en) 2016-05-11 2018-12-21 通用电气医疗集团生物工艺研发股份公司 Isolation medium
DK3455244T3 (en) * 2016-05-11 2022-06-07 Cytiva Bioprocess R & D Ab MUTANT IMMUNOGLOBULIN BINDING POLYPEPTIDES
KR101857953B1 (en) 2016-07-06 2018-05-16 아미코젠주식회사 Mutated immunoglobulin binding protein with enhanced alkali-tolerance
SG11201901066UA (en) 2016-08-11 2019-03-28 Navigo Proteins Gmbh Novel alkaline stable immunoglobulin-binding proteins
JP2020504172A (en) 2016-12-12 2020-02-06 フラー エス．アー．エール．エル． Compositions and methods for increasing the immunoglobulin binding capacity of immunoglobulin binding polypeptides and oligopeptides
CN106596822B (en) * 2016-12-16 2018-01-19 南京市产品质量监督检验院 A kind of detection method of Staphylococcus aureus in food phenol soluble regulatory albumen
GB201708277D0 (en) * 2017-05-24 2017-07-05 Ge Healthcare A Recombinant protein
WO2019030156A1 (en) 2017-08-07 2019-02-14 Repligen Corporation Fc binding proteins with cysteine in the c-terminal helical region
US11414466B2 (en) 2017-11-07 2022-08-16 Navigo Proteins Gmbh Fusion proteins with specificity for ED-B and long serum half-life for diagnosis or treatment of cancer
EP3708667A4 (en) 2017-11-09 2021-11-17 Tosoh Corporation Immunoglobulin-binding protein
KR102055708B1 (en) 2018-06-26 2019-12-13 동일플랜트 주식회사 Draft type condenser with improved of cooling efficiency by using heat pipe inserted in the steam turbine output steam pipe
EP3842536A4 (en) 2018-08-24 2023-01-18 JSR Corporation Immunoglobulin-binding protein, and affinity carrier using same
GB201904125D0 (en) 2019-03-26 2019-05-08 Ge Healthcare Bio Sciences Ab Method for sanitization of a chromatography column
CN112210013A (en) * 2019-07-03 2021-01-12 拜奥普罗塞亚科技有限责任公司 Alkali-tolerant affinity chromatography ligands
JP2022548394A (en) * 2019-09-24 2022-11-18 リジェネロン・ファーマシューティカルズ・インコーポレイテッド Systems and methods for use and regeneration of chromatography
EP3875472A1 (en) * 2020-03-06 2021-09-08 Navigo Proteins Gmbh Novel immunoglobulin binding polypeptides
GB202113626D0 (en) 2021-09-24 2021-11-10 Cytiva Bioprocess R & D Ab FC binding polypeptides
GB202203478D0 (en) 2022-03-14 2022-04-27 Cytiva Bioprocess R & D Ab Vh3 binding polypeptides
CN115850408A (en) * 2022-09-01 2023-03-28 西安蓝晓科技新材料股份有限公司 Polypeptide, fusion type polymer protein and application thereof

Family Cites Families (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8204810L (en) 1982-08-23 1984-02-24 Pharmacia Fine Chemicals Ab HYBRID DNA MOLECULE, TRANSFORMED MICROORGANISM AND PROCEDURE TO MAKE PROTEIN A
US5151350A (en) 1982-10-27 1992-09-29 Repligen Corporation Cloned genes encoding recombinant protein a
US4617266A (en) 1983-04-28 1986-10-14 Genex Corporation Production of Protein A
NZ218050A (en) 1985-11-13 1989-05-29 Wistar Inst Test for the presence of htlv-1v
SE8505922D0 (en) 1985-12-13 1985-12-13 Kabigen Ab CONSTRUCTION OF AN IGG BINDING PROTEIN TO FACILITATE DOWNSTREAM PROCESSING USING PROTEIN ENGINEERING
US5260373A (en) 1987-03-13 1993-11-09 Repligen Corporation Immobilized immunoglobulin-binding proteins
US5084559A (en) 1987-03-27 1992-01-28 Repligen Corporation Protein a domain mutants
US5089473A (en) 1988-08-29 1992-02-18 Monsanto Company Somatotropin variants and their use
GB8902770D0 (en) 1989-02-08 1989-03-30 Bioprocessing Ltd Improvements in or relating to supports for immunoaffinity separations
US4879378A (en) 1989-03-30 1989-11-07 Union Carbide Chemicals And Plastics Company Inc. Polysiloxanes with pendant sterically hindered phenol moiety connected to the silicon atom via a carbonylyoxy-containing link
US5401650A (en) 1990-10-24 1995-03-28 The Mount Sinai School Of Medicine Of The City University Of New York Cloning and expression of biologically active α-galactosidase A
US5198531A (en) 1991-06-14 1993-03-30 Research Diagnostic Antibodies Polymeric resin for peptide synthesis
EP0863210A3 (en) 1991-07-25 1999-09-22 Oriental Yeast Co., Ltd. Immunoglobulin-binding artificial protein
US5240680A (en) 1991-12-19 1993-08-31 Chiron Corporation Automated apparatus for use in peptide synthesis
US5573905A (en) 1992-03-30 1996-11-12 The Scripps Research Institute Encoded combinatorial chemical libraries
SE9400088D0 (en) 1994-01-14 1994-01-14 Kabi Pharmacia Ab Bacterial receptor structures
SE9503925D0 (en) 1995-11-07 1995-11-07 Pharmacia Biotech Ab Separation medium for IgG
US6447777B1 (en) 1996-03-29 2002-09-10 David S. Terman Polymerized staphylococcal protein a for treatment of diseases
US6013763A (en) 1996-06-04 2000-01-11 Genentech, Inc. Peptide variants of protein A
US5856452A (en) 1996-12-16 1999-01-05 Sembiosys Genetics Inc. Oil bodies and associated proteins as affinity matrices
US7026446B1 (en) 1997-12-24 2006-04-11 Diatech Pty Ltd. Bifunctional molecules
GB9823071D0 (en) 1998-10-21 1998-12-16 Affibody Technology Ab A method
US6589529B1 (en) 1998-10-30 2003-07-08 Children's Hospital Medical Center Rotavirus subunit vaccine
SE9901379D0 (en) 1999-04-19 1999-04-19 Pharmacia & Upjohn Ab Receptor structures
US6602977B1 (en) 1999-04-19 2003-08-05 Biovitrum Ab Receptor structures
AU777005B2 (en) 1999-05-15 2004-09-30 University Of California, San Diego Protein A based binding domains with desirable activities
US7163686B1 (en) 1999-05-15 2007-01-16 The Regents Of The University Of California Protein A based binding domains with desirable activities
AU2002362197A1 (en) 2001-12-28 2003-07-24 Chugai Seiyaku Kabushiki Kaisha Method of stabilizing protein
US7709209B2 (en) 2002-03-25 2010-05-04 Ge Healthcare Bio-Sciences Ab Protein ligands
SE0200943D0 (en) 2002-03-25 2002-03-25 Amersham Biosciences Ab Mutant protein
US7083948B1 (en) 2002-12-24 2006-08-01 Immunex Corporation Polypeptide purification reagents and methods for their use
GB0304576D0 (en) 2003-02-28 2003-04-02 Lonza Biologics Plc Protein a chromatography
DK1601697T3 (en) 2003-02-28 2007-10-01 Lonza Biologics Plc Purification of antibody by protein A and ion exchange chromatography
WO2005003156A1 (en) 2003-07-04 2005-01-13 Affibody Ab Polypeptides having binding affinity for her2
US7956165B2 (en) 2003-07-24 2011-06-07 Affisink Biotechnology Ltd. Compositions and methods for purifying and crystallizing molecules of interest
CA2541015A1 (en) 2003-10-03 2005-04-14 Genentech, Inc. Igf binding proteins
EP1564286A1 (en) * 2004-02-11 2005-08-17 Université de Liège Hybrid proteins of beta-lactamase class A
JPWO2006004067A1 (en) 2004-07-06 2008-04-24 株式会社カネカ Method for producing protein A-like protein using Brevibacillus bacteria
US8728828B2 (en) 2004-12-22 2014-05-20 Ge Healthcare Bio-Sciences Ab Purification of immunoglobulins
US20080254551A1 (en) 2004-12-30 2008-10-16 Achsel Tilmann Immunoprecipitaion-Based Method to Purify and Characterise Biological Macromolecular Complexes
WO2006092338A2 (en) 2005-03-01 2006-09-08 Affibody Ab Tnf-alpha binding polypeptide , uses thereof and methods employing it
JP2006304633A (en) 2005-04-26 2006-11-09 Apro Life Science Institute Inc Immunoglobulin-binding protein
SG162806A1 (en) * 2005-06-17 2010-07-29 Elan Pharma Int Ltd Methods of purifying anti a beta antibodies
JP2009503115A (en) 2005-08-03 2009-01-29 アールキュー バイオサイエンス インク Methods and compositions for diagnosing IgA and IgM mediated nephropathy
EP1910433B1 (en) 2005-08-03 2014-11-05 Merck Patent GmbH Crosslinked hydrophile polymer
WO2007061936A2 (en) 2005-11-18 2007-05-31 New England Medical Center Hospitals, Inc. Clearance of abnormal iga1 in iga1 deposition diseases
US7833723B2 (en) 2006-01-06 2010-11-16 Millipore Corporation Affinity chromatography matrices and methods of making and using the same
WO2007097361A1 (en) 2006-02-21 2007-08-30 Protenova Co., Ltd. Immunoglobulin affinity ligand
US20080096819A1 (en) 2006-05-02 2008-04-24 Allozyne, Inc. Amino acid substituted molecules
GB0610776D0 (en) 2006-05-31 2006-07-12 Univ Bath Novel applications for staphylococcus aureus Sbi protein
CN101522278B (en) * 2006-09-29 2016-08-10 通用电气健康护理生物科学股份公司 The chromatography ligand comprising the domain C from staphylococcal protein A separated for antibody
JP5004165B2 (en) 2006-10-10 2012-08-22 独立行政法人産業技術総合研究所 Protein suitable for protein orientation control immobilization
EP2099932A4 (en) 2006-12-06 2009-11-18 Repligen Corp Nucleic acids encoding recombinant protein a
US8362217B2 (en) 2006-12-21 2013-01-29 Emd Millipore Corporation Purification of proteins
JP5361738B2 (en) 2007-01-22 2013-12-04 ジェネンテック， インコーポレイテッド Purification of polyelectrolyte precipitates and proteins
JP2008266221A (en) 2007-04-20 2008-11-06 National Institute Of Advanced Industrial & Technology Immobilized protein immobilized at one amino terminal in controlled arrangement
JP5522723B2 (en) 2007-05-21 2014-06-18 ノマディックバイオサイエンス株式会社 Novel polypeptide, material for affinity chromatography, and method for separation and / or purification of immunoglobulin
SG149759A1 (en) 2007-07-10 2009-02-27 Millipore Corp Media for affinity chromatography
JP2009071766A (en) 2007-09-18 2009-04-02 Panasonic Corp Signal receiving terminal apparatus
CN103396480A (en) 2008-05-15 2013-11-20 诺沃—诺迪斯克有限公司 Antibody purification process
WO2009146755A1 (en) 2008-06-05 2009-12-10 Affibody Ab Polypeptide
US8592555B2 (en) 2008-08-11 2013-11-26 Emd Millipore Corporation Immunoglobulin-binding proteins with improved specificity
SG195555A1 (en) 2008-12-24 2013-12-30 Emd Millipore Corp Caustic stable chromatography ligands
WO2010080065A1 (en) 2009-01-12 2010-07-15 Ge Healthcare Bio-Sciences Ab Affinity chromatography matrix
EP2412809B1 (en) 2009-03-24 2017-08-09 Kaneka Corporation Protein having affinity for immunoglobulin, and immunoglobulin-binding affinity ligand
CN103228328A (en) * 2010-11-29 2013-07-31 通用电气健康护理生物科学股份公司 Affinity chromatography matrix
CN103269761B (en) 2010-12-20 2016-05-18 通用电气健康护理生物科学股份公司 affinity chromatography matrix
US10065995B2 (en) * 2011-03-25 2018-09-04 Kaneka Corporation Protein for affinity-separation matrix
SG186552A1 (en) * 2011-06-08 2013-01-30 Emd Millipore Corp Chromatography matrices including novel staphylococcus aureus protein a based ligands

Also Published As

Publication number Publication date
SG186552A1 (en) 2013-01-30
AU2019200368A1 (en) 2019-02-07
TW201305191A (en) 2013-02-01
TWI570134B (en) 2017-02-11
US20150080558A1 (en) 2015-03-19
WO2013109302A2 (en) 2013-07-25
KR101928697B1 (en) 2018-12-12
JP6018120B2 (en) 2016-11-02
KR20180035201A (en) 2018-04-05
JP6586131B2 (en) 2019-10-02
CN105457612A (en) 2016-04-06
JP6189493B2 (en) 2017-08-30
EP3053931A2 (en) 2016-08-10
JP2012254981A (en) 2012-12-27
EP3053931A3 (en) 2016-10-26
KR20120137259A (en) 2012-12-20
DK2532672T3 (en) 2018-06-14
RU2644680C1 (en) 2018-02-13
ES2710204T3 (en) 2019-04-23
US9018305B2 (en) 2015-04-28
US8895706B2 (en) 2014-11-25
AU2019200368B2 (en) 2021-03-11
US20160168194A1 (en) 2016-06-16
EP2532672A3 (en) 2013-04-03
US9234010B2 (en) 2016-01-12
TW201716427A (en) 2017-05-16
TW201542586A (en) 2015-11-16
KR20140044348A (en) 2014-04-14
US20130046056A1 (en) 2013-02-21
JP5756428B2 (en) 2015-07-29
US20150252085A1 (en) 2015-09-10
US8754196B2 (en) 2014-06-17
KR101844107B1 (en) 2018-03-30
JP2017019792A (en) 2017-01-26
TWI638828B (en) 2018-10-21
JP2018021038A (en) 2018-02-08
DK3053931T3 (en) 2019-03-04
ES2671722T3 (en) 2018-06-08
IL253992A0 (en) 2017-10-31
AU2017200616B2 (en) 2018-11-01
CN105457612B (en) 2018-08-21
AU2012366229A1 (en) 2013-11-07
EP3053931B1 (en) 2019-01-02
US20140296434A1 (en) 2014-10-02
EP2532672B1 (en) 2018-04-04
JP2014193892A (en) 2014-10-09
CN102895960B (en) 2016-02-10
CN102895960A (en) 2013-01-30
WO2013109302A3 (en) 2013-10-17
AU2012366229B2 (en) 2016-11-17
RU2595430C2 (en) 2016-08-27
AU2012366229C1 (en) 2017-03-09
SG10201604554WA (en) 2016-07-28
IL253992B (en) 2019-01-31
EP2532672A2 (en) 2012-12-12
US9376474B1 (en) 2016-06-28
RU2013154493A (en) 2015-07-20
IL229774A (en) 2017-08-31
AU2017200616A1 (en) 2017-02-23
TWI596108B (en) 2017-08-21
KR101464040B1 (en) 2014-11-20

Similar Documents

Publication Publication Date Title
IL253992B (en) Chromatography matrices including novel staphylococcus aureus protein a based ligands
ZA201308600B (en) Novel pesticidal pyrazole compounds
EP2690960A4 (en) Pesticidal mixtures
ZA201407330B (en) Cross-reactive staphylococcus aureus antibody
LT2890394T (en) Stabilised proteins for immunising against staphylococcus aureus
EP2763539A4 (en) Antibacterial compounds
ZA201306232B (en) Pesticidal composition
HK1198588A1 (en) Protein purification by anion exchange chromatography
HK1198653A1 (en) Protein purification by anion exchange chromatography
EP2797420A4 (en) Pest control composition
EP2758405A4 (en) Novel antimicrobial compounds
EP2797419A4 (en) Pest control composition
ZA201207011B (en) A novel pesticidal composition
GB201105633D0 (en) Antibotic compounds
EP2773655A4 (en) Protective vaccine based on staphylococcus aureus sa2074 protein
EP2773370A4 (en) Protective vaccine based on staphylococcus aureus sa2451 protein
GB201105525D0 (en) Pesticidal compositon
AU2011903957A0 (en) Novel antimicrobial compounds
AU2011903946A0 (en) Novel antimicrobial compounds
AU339747S (en) Hedge trimmer
AU339745S (en) Hedge trimmer
AU339746S (en) Hedge trimmer
AU339743S (en) Hedge trimmer
AU339744S (en) Hedge trimmer
AU339742S (en) Hedge trimmer